| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2366* | 2021 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2128 | 2017 |
| Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Journal of British Surgery 107 (11), 1440-1449, 2020 | 1510 | 2020 |
| Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection L Townsend, AH Dyer, K Jones, J Dunne, A Mooney, F Gaffney, ... PloS one 15 (11), e0240784, 2020 | 957 | 2020 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 731* | 2014 |
| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 580 | 2008 |
| COVID19 coagulopathy in Caucasian patients H Fogarty, L Townsend, C Ni Cheallaigh, C Bergin, I Martin‐Loeches, ... British journal of haematology 189 (6), 1044-1049, 2020 | 570* | 2020 |
| Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle-and high-income countries BJA: British Journal of Anaesthesia 117 (5), 601-609, 2016 | 537 | 2016 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 476 | 2021 |
| Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel V Soriano, M Sulkowski, C Bergin, A Hatzakis, P Cacoub, C Katlama, ... Aids 16 (6), 813-828, 2002 | 396 | 2002 |
| Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity L Townsend, J Dowds, K O’Brien, G Sheill, AH Dyer, B O’Kelly, JP Hynes, ... Annals of the American Thoracic Society 18 (6), 997-1003, 2021 | 328 | 2021 |
| Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized … GD Perkins, C Ji, BA Connolly, K Couper, R Lall, JK Baillie, JM Bradley, ... Jama 327 (6), 546-558, 2022 | 324 | 2022 |
| Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international … I Roberts, H Shakur-Still, A Afolabi, A Akere, M Arribas, A Brenner, ... The Lancet 395 (10241), 1927-1936, 2020 | 319 | 2020 |
| Persistent endotheliopathy in the pathogenesis of long COVID syndrome H Fogarty, L Townsend, H Morrin, A Ahmad, C Comerford, E Karampini, ... Journal of thrombosis and haemostasis 19 (10), 2546-2553, 2021 | 287 | 2021 |
| Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV … Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1145-1155, 2008 | 258 | 2008 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 256 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 242 | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 236 | 2022 |
| Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ... Clinical Infectious Diseases 56 (7), 1004-1017, 2013 | 224 | 2013 |
| Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response L Townsend, H Fogarty, A Dyer, I Martin‐Loeches, C Bannan, ... Journal of Thrombosis and Haemostasis 19 (4), 1064-1070, 2021 | 211 | 2021 |
